Heard on the Street: Pfizer's accord on price cuts with President Trump clears a cloud over the whole pharma industry

Core Viewpoint - The company's agreement with the president alleviates uncertainty affecting the entire sector [1] Group 1 - The accord is expected to have a positive impact on the industry as it resolves previous concerns [1] - This development may lead to increased investor confidence across the sector [1] - The agreement is seen as a significant step towards stabilizing the market environment [1]